Liderazgo

Joe Kiani is the Founder and Executive Chairman of Willow Laboratories, a health and wellness innovator dedicated to advancing noninvasive monitoring solutions and reinventing diabetes care. Prior to Willow, Kiani founded Masimo in 1989 and led it from a garage startup to a publicly traded medical technology company with over $2 billion in revenue. He holds more than 600 patents and co-invented measure-through-motion pulse oximetry. His technology is used to monitor over 200 million patients annually. He also founded the Patient Safety Movement Foundation to help eliminate preventable hospital deaths. Kiani is co-founder and CEO of Like Minded Labs, a media technology company reimagining virtual collaboration. In addition, he serves as Chairman of Clarity, a breast cancer-focused medtech company, and SMS Biotech, which is democratizing adult stem cell technologies for human health, and is an investor and board member at CDX Medical Technologies (a pioneer in ECMO pump innovation), MY01 (transforming diagnosis of limb perfusion injuries), and IRAMED (a leader in MRI-compatible patient monitoring and infusion systems).

Mohamed Diab is an accomplished technology leader in the medical device field, bringing decades of expertise in non-invasive sensing and physiological monitoring to guide Willow Laboratories’ research, development, and product innovation. With an extensive patent portfolio spanning multi-wavelength sensors, alarm systems, and advanced non-invasive analytical devices, he leads cross-functional teams in engineering, product design, and regulatory strategy. A graduate of California State University, Fullerton, Diab previously held senior technical leadership roles at Masimo Corporation. As CTO, he advances Willow’s mission to deliver breakthrough medical technologies that enhance patient care and extend healthspan through safety, accuracy, and scalability.

Tao Levy joined the company in 2025 as Chief Financial Officer, overseeing all financial and administrative operations. With extensive experience in financial services and the medical device industry, he plays a key role in supporting the company’s growth strategy. Before joining, Tao served as Executive Vice President of Business Development at Masimo Corporation, a publicly traded medical device manufacturer, where he was part of the executive management team. In this role, he led inorganic growth initiatives, including M&A, partnerships, licensing agreements, and investments. He also brings over a decade of experience as a Senior Equity Research Analyst covering the medical devices sector at various firms, including Deutsche Bank and Wedbush Securities. Tao holds a B.A. in Biology from the University of Pennsylvania.

Nicole Campagna joined Willow Laboratories in November 2025, bringing more than 15 years of experience in commercial strategy, B2B growth, and client success across the digital health and medical-device sectors. She has a proven track record of building and scaling enterprise partnerships, developing high-performing teams, and driving population-health outcomes for employers, payers, and health systems. Nicole began her career in M&A at Philips Respironics, working across medical-device acquisitions and building a strong foundation in product, market, and deal strategy. She later spent more than a decade at WeightWatchers, where she built and scaled the company’s B2B business from the ground up—leading employer and payer partnerships, commercial strategy, and client-success operations focused on weight health and chronic-condition prevention. At Willow Laboratories, Nicole leads commercialization and strategy for Nutu — a solution designed to help prevent type 2 diabetes, improve weight health, and support payers and employers in driving meaningful population-health outcomes.

Diane Perez joined Willow Laboratories in November 2024 as Vice President of Business Development, bringing over 25 years of experience in medical communication, strategic clinical collaboration, and business expansion. A medical doctor, Diane has been a prominent health communicator in international media, educating audiences on health and wellness through trusted, accessible content. She has hosted medical TV shows and participates in several media outlets, providing expert advice on healthy living. Dr. Perez has been a major contributor to advancing health initiatives and legislative changes for critical newborn health screenings in Mexico. As an accomplished author, she has published two books with Penguin Random House on 200 diseases and a healthy lifestyle to lose weight. Diane earned her medical degree from the National Autonomous University of Mexico (UNAM) and a Master of Healthcare Management from the Harvard School of Public Health.

With over 30 years of experience in biotech, medical devices, advertising, supply chain, and production studios, Roger Wu combines strategic vision with hands-on expertise to deliver impactful solutions. As Vice President of Creative Services, he has a proven track record of developing branding, marketing, and design strategies that enhance engagement and drive business growth. A holder of multiple design patents, Roger excels at transforming complex ideas into compelling visual solutions, fostering innovation, and leading cross-industry collaboration.

Mike joined Willow Labs in November 2024, bringing more that 30 years of global manufacturing and operations experience in the medical device industry with a proven track record of executing and delivering new products while optimizing product cost and supply chains on legacy products. Mike has successfully built and led supply chain, manufacturing, and sustaining engineering teams to bring new products to market, expanding product portfolios and operations capabilities aligned with growth objectives. Mike will oversee the development and scaling of Willow’s Manufacturing Team and Global Operations. Mike holds a B.S. in Mechanical Engineering from San Diego State University.

Marty Wexler se unió a Willow Laboratories en marzo de 2025 como Vicepresidente de Ventas y Cuentas Nacionales, aportando más de 40 años de experiencia en ventas, gestión de ventas y liderazgo de cuentas corporativas. Antes de incorporarse a Willow, Marty ocupó diversos puestos de liderazgo en Masimo, el más reciente como Director Sénior de Cuentas Corporativas. En este cargo, desempeñó un papel fundamental en la adopción de las tecnologías de Masimo por parte de importantes sistemas de salud y redes integradas de atención médica, aprovechando su experiencia en lanzamientos de productos, desarrollo de estrategias de mercado y negociación de contratos. Su trayectoria en Masimo también incluyó puestos clave en gestión de ventas, gestión estratégica de cuentas y liderazgo de cuentas corporativas. Anteriormente, Marty fue Vicepresidente de Ventas en LifeSync Corporation y ocupó diversos puestos de gestión de ventas en otras empresas de dispositivos médicos. A lo largo de su carrera, ha impulsado de forma constante el crecimiento y la rentabilidad de los negocios en mercados multimillonarios, aplicando su profundo conocimiento del sector y su enfoque estratégico de ventas.

Vincent Schneider se unió a la compañía en septiembre de 2025 como Vicepresidente Internacional de Desarrollo de Negocios y Ventas, supervisando nuestras operaciones fuera de Estados Unidos. Con más de 30 años de experiencia en liderazgo internacional en los sectores de salud, dispositivos médicos, informática y marcas de lujo, Vincent ha liderado con éxito importantes iniciativas de transformación tanto en entornos de alto crecimiento como en aquellos con bajo rendimiento. Su experiencia abarca fusiones y adquisiciones, integración posterior a la fusión y expansión comercial global. Antes de unirse a la compañía, Vincent fue Vicepresidente de Desarrollo Estratégico de Negocios OEM en Masimo Corporation, empresa líder en tecnología médica que cotiza en bolsa.

Mark Helbing se unió a Willow Laboratories en junio de 2025 como Vicepresidente de Gobierno y Mercados Estratégicos, aportando más de tres décadas de liderazgo en asuntos gubernamentales, ventas institucionales, marketing y desarrollo de negocios de tecnología sanitaria en los sectores de dispositivos médicos, equipo médico-quirúrgico y bienes de capital. Cuenta con una trayectoria comprobada en la creación y dirección de equipos de alto rendimiento, la definición de estrategias de mercado y el cultivo de relaciones de confianza con agencias clave, como el Departamento de Defensa y la Administración de Veteranos. A lo largo de su carrera, ha impulsado un crecimiento significativo a través de cuentas nacionales, importantes sistemas de salud y alianzas estratégicas, posicionando consistentemente a las organizaciones para el éxito a largo plazo en mercados gubernamentales y empresariales complejos.